Elliott Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-20,428,961
| Closed | -$17.6M | – | 49 |
|
|
2019
Q4 | $17.6M | Hold |
20,428,961
| – | – | 0.15% | 43 |
|
|
2019
Q3 | $11.4M | Hold |
20,428,961
| – | – | 0.1% | 47 |
|
|
2019
Q2 | $10.6M | Hold |
20,428,961
| – | – | 0.07% | 52 |
|
|
2019
Q1 | $9.19M | Hold |
20,428,961
| – | – | 0.06% | 61 |
|
|
2018
Q4 | $9.81M | Hold |
20,428,961
| – | – | 0.07% | 64 |
|
|
2018
Q3 | $10.8M | Sell |
20,428,961
-25,600
| -0.1% | -$13.7K | 0.05% | 60 |
|
|
2018
Q2 | $10.2M | Hold |
20,454,561
| – | – | 0.05% | 64 |
|
|
2018
Q1 | $8.64M | Hold |
20,454,561
| – | – | 0.05% | 61 |
|
|
2017
Q4 | $7.77M | Hold |
20,454,561
| – | – | 0.05% | 54 |
|
|
2017
Q3 | $7.36M | Hold |
20,454,561
| – | – | 0.04% | 71 |
|
|
2017
Q2 | $7.77M | Hold |
20,454,561
| – | – | 0.05% | 74 |
|
|
2017
Q1 | $9.21M | Hold |
20,454,561
| – | – | 0.07% | 62 |
|
|
2016
Q4 | $7.77M | Hold |
20,454,561
| – | – | 0.06% | 66 |
|
|
2016
Q3 | $5.52M | Hold |
20,454,561
| – | – | 0.05% | 68 |
|
|
2016
Q2 | $4.91M | Hold |
20,454,561
| – | – | 0.04% | 73 |
|
|
2016
Q1 | $2.33M | Hold |
20,454,561
| – | – | 0.02% | 62 |
|
|
2015
Q4 | $2.3M | Buy |
20,454,561
+663,461
| +3% | +$93.7K | 0.03% | 70 |
|
|
2015
Q3 | $3.77M | Buy |
19,791,100
+596,100
| +3% | +$203K | 0.07% | 54 |
|
|
2015
Q2 | $13.4M | Buy |
19,195,000
+10,581,000
| +123% | +$7.32M | 0.19% | 36 |
|
|
2015
Q1 | $5.84M | Buy |
+8,614,000
| New | +$6.02M | 0.07% | 56 |
|
Elliott Management's GCVRZ Position: Q1 2020 in Review
Elliott Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 20,428,961 shares — an estimated $17.6M sold.
Elliott Management first reported a position in GCVRZ in Q1 2015 and held it in 20 quarters. The position peaked at $17.6M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Elliott Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Elliott Management sold 20,428,961 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $17.6M.
- Elliott Management first reported a position in Sanofi Contingent Value Rights in Q1 2015 and held it in 20 quarters.
- Elliott Management's Sanofi Contingent Value Rights position peaked at $17.6M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Elliott Management's 13F filing for Q1 2020.